Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson settles U.S. bribery charges

By Parija Kavilanz, senior writer

NEW YORK (CNNMoney) -- The Securities and Exchange Commission on Friday charged Johnson & Johnson with bribing doctors in several countries to prescribe its drugs and medical devices.

The company has agreed to pay $70 million to settle the charges, without admitting or denying the allegations.

This is the latest setback amid mounting problems for the pharmaceutical giant. Johnson & Johnson's (JNJ, Fortune 500), drugmaking arm McNeil Consumer Healthcare is already under federal supervision due to numerous recalls of its Tylenol and other non-prescription medicines over the past year.

J&J also faces numerous lawsuits files by patients who received defective hip replacement devices manufactured by its DePuy Orthopaedics unit.

The SEC alleges that since at least 1998, J&J subsidiaries paid bribes to doctors in Greece to select its surgical implants, to doctors and hospital administrators in Poland to win contracts to doctors in Romania to prescribe J&J drugs.

The agency said J&J subsidiaries also paid kickbacks to Iraq to obtain 19 contracts under the United Nations Oil for Food Program.

J&J subsidiaries, employees and agents used slush funds, sham civil contracts with doctors, and off-shore companies in the Isle of Man to carry out the bribery. These acts violate the Foreign Corrupt Practices Act, the agency said.

"The message in this is plain. Any competitive advantage gained through corruption is a mirage," Robert Khuzami, Director of the SEC's Division of Enforcement, said in a statement.

"J&J chose profit margins over compliance with the law by acquiring a private company for the purpose of paying bribes, and using sham contracts, off-shore companies, and slush funds to cover its tracks," he said.

J&J said it hopes to reach a settlement of a related investigation by the U.K. Serious Fraud Office in the coming days.

J&J CEO William Weldon said the company reported the improper payments to the government more than four years ago and has taken full responsibility.

"We are deeply disappointed by the unacceptable conduct that led to these violations," he said, adding that the company is committed to making sure this doesn't happen again." To top of page

Index Last Change % Change
Dow 17,812.19 19.51 0.11%
Nasdaq 5,102.81 0.33 0.01%
S&P 500 2,089.14 2.55 0.12%
Treasuries 2.24 -0.01 -0.31%
Data as of 7:33am ET
Company Price Change % Change
General Electric Co 30.66 0.07 0.23%
Pfizer Inc 31.97 0.64 2.04%
Bank of America Corp... 17.47 0.01 0.06%
Freeport-McMoRan Inc... 8.30 0.30 3.75%
Synchrony Financial 31.34 -0.21 -0.67%
Data as of Nov 24


The pharmaceutical company that increased the price of a drug used by AIDS and cancer patients 5,000% is slashing the price for hospitals. More

The financial deck appears to be stacked against blacks and Hispanics in America. They earn considerably less. They are more likely to be unemployed or in poverty and they are less likely to own a home. Yet despite all this, blacks and Hispanics are far more optimistic about being able to live the American Dream these days than whites. More

Watsi crowdfunds donations to cover healthcare costs of those in need. And it's seeing a surprising trend: micro-donations via the popular Chinese social networking app, WeChat. More

Some of the coolest toys this year are from small businesses. Here are 10 hot toys that just might be a smash hit this holiday season. More

Your new credit card might be safer, but it could lead to more headaches at the check-out line this holiday season. More